Thursday, October 23, 2014
Arch Therapeutics Negotiating a Collaboration Agreement With CURAM Centre for Research in Medical Devices | Publicwire
Arch Therapeutics, Inc. (OTCQB: ARTH), developer of the AC5 Surgical Hemostat(TM), announced today that it is negotiating a potential collaboration agreement with CURAM Centre for Research in Medical Devices.
http://bit.ly/ZJG8on
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment